Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells - PubMed (original) (raw)
. 2004 Jun 7;199(11):1567-75.
doi: 10.1084/jem.20032058. Epub 2004 Jun 1.
Johan Verhagen, Alison Taylor, Fariba Karamloo, Christian Karagiannidis, Reto Crameri, Sarah Thunberg, Günnur Deniz, Rudolf Valenta, Helmut Fiebig, Christian Kegel, Rainer Disch, Carsten B Schmidt-Weber, Kurt Blaser, Cezmi A Akdis
Affiliations
- PMID: 15173208
- PMCID: PMC2211782
- DOI: 10.1084/jem.20032058
Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells
Mübeccel Akdis et al. J Exp Med. 2004.
Abstract
The mechanisms by which immune responses to nonpathogenic environmental antigens lead to either allergy or nonharmful immunity are unknown. Single allergen-specific T cells constitute a very small fraction of the whole CD4+ T cell repertoire and can be isolated from the peripheral blood of humans according to their cytokine profile. Freshly purified interferon-gamma-, interleukin (IL)-4-, and IL-10-producing allergen-specific CD4+ T cells display characteristics of T helper cell (Th)1-, Th2-, and T regulatory (Tr)1-like cells, respectively. Tr1 cells consistently represent the dominant subset specific for common environmental allergens in healthy individuals; in contrast, there is a high frequency of allergen-specific IL-4-secreting T cells in allergic individuals. Tr1 cells use multiple suppressive mechanisms, IL-10 and TGF-beta as secreted cytokines, and cytotoxic T lymphocyte antigen 4 and programmed death 1 as surface molecules. Healthy and allergic individuals exhibit all three allergen-specific subsets in different proportions, indicating that a change in the dominant subset may lead to allergy development or recovery. Accordingly, blocking the suppressor activity of Tr1 cells or increasing Th2 cell frequency enhances allergen-specific Th2 cell activation ex vivo. These results indicate that the balance between allergen-specific Tr1 cells and Th2 cells may be decisive in the development of allergy.
Figures
Figure 1.
Allergen-specific IL-4-, IFN-γ–, and IL-10–secreting T cells represent Th2-, Th1-, and Tr1-like cells. (A) IL-10, IL-13, IFN-γ, and TGF-β mRNA were quantified by real-time PCR immediately after isolation of Der p 1– or Bet v 1–specific, cytokine-secreting T cells and their relative expression compared with the housekeeping gene EF-1α. The same results were obtained in three independent experiments. (B) Bet v 1–, Der p 1–, and Cor a 1–specific IL-4–, IFN-γ–, and IL-10–secreting T cells (one allergic and one healthy donor each; closed symbols, allergic donors; open symbols, healthy donors) were in vitro expanded for 2 wk, and their cytokine profile was determined in supernatants by ELISA 72 h after anti-CD2, anti-CD3, and anti-CD28 mAb stimulation. (C) Intracytoplasmic cytokine profile of in vitro–expanded allergen-specific T cells (the same results were obtained in 10 additional experiments). Percentage of positive cells is shown in each quadrant.
Figure 2.
Specificity and growth requirements of purified allergen-specific T cells. (A) Bet v 1–, Der p 1–, and Cor a 1–specific IL-4–, IFN-γ–, and IL-10–secreting T cells (one allergic and one healthy donor each; closed symbols, allergic donors; open symbols, healthy donors) were purified and in vitro expanded, and 5 × 105 cells were cocultured with 5 × 105 autologous irradiated PBMCs as an APC source in the presence of the same antigen. [3H]Thymidine incorporation (TdR) was determined after 5 d. *, P < 0.001. (B) Purified Bet v 1–specific and Der p 1–specific T cells did not show any proliferative response to different control antigens (two representative of six experiments are shown; mean ± SD of triplicate cultures). TT, tetanus toxoid; us, unstimulated. (C) Growth factor requirements of antigen-specific IL-10–secreting T cells. After purification, Bet v 1– or Der p 1–specific IL-10–secreting T cells were first expanded for 10 d in the presence of IL-2, washed, and cultured (5 × 104 cells) with 1-nM doses of different cytokines. [3H]Thymidine incorporation was determined after 3 d (mean ± SD of three independent experiments are shown).
Figure 3.
Increased frequency of allergen-specific Tr1 cells in healthy individuals and Th2 cells in allergic individuals. (A) Frequency of Der p 1– and Bet v 1–specific, cytokine-secreting CD4+ T cells from eight allergic individuals and Cor a 1–, Bet v 1-, Der p 1–, and Pyr c 5–specific, cytokine-secreting CD4+ T cells from 15 healthy individuals out of pollen season. (B) Frequency of Der p 1–specific T cells in six allergic and six healthy, and Bet v 1–specific T cells in three allergic and three healthy individuals by ELISPOT assay. *, P < 0.01; **, P < 0.001.
Figure 4.
Antigen-specific suppression by Tr1 cells. (A) Der p 1–specific and Bet v 1–specific IL-4–secreting and IL-10–secreting T cells were purified from healthy individuals. Their frequency was calculated in CD4+ T cells, and 2 × 105 PBMCs were immediately reconstituted by increasing their frequency by 10 times (IL-4–secreting T cells, 0.02–0.2%; IL-10–secreting T cells, 0.05–0.5%). Cells were stimulated with the respective antigens and PPD. (B) Der p 1–specific IL-4–secreting and IL-10–secreting T cells were purified and in vitro expanded by IL-2/IL-4 and IL-2/IL-15, respectively. 2 × 105 PBMCs were enriched with 1,000 Der p 1–specific IL-4– or IL-10–secreting T cells or their combinations in IL-4–secreting/IL-10–secreting T cell ratios 1,000/1,000 (1:1), 1,000/500 (2:1), 1,000:250 (4:1), and 1,000:125 (8:1). Cells were stimulated with 0.3 μM Der p 1 or 1 μg/ml PPD. Der p 1–specific, IL-10–secreting T cells added to PPD-stimulated PBMC cultures at indicated numbers did not show any suppression. (C) The same experimental design as in A was used, and cells were stimulated with both Der p 1 and Bet v 1 (0.3 μM each). (A–C) [3H]Thymidine incorporation was determined after 5 d. The same results were obtained in three other experiments. *, P < 0.001. (D) 105 PBMCs were stimulated with anti-CD3 in the presence of different amounts of IL-10–secreting and IL-4-secreting T cells. [3H]Thymidine incorporation was determined after 3 d. Data represent two different experiments. *, P < 0.01.
Figure 5.
Expression of suppressor molecules on IL-10–secreting T cells. (A) Immediately after purification, antigen-specific IL-10–secreting T cells of healthy individuals were analyzed for intracytoplasmic IL-10, surface IL-10R, CTLA-4, CD25, and PD-1 by flow cytometry. Data are compared with CD3+ T cells of the same donor stimulated with the same antigen. (B) TGF-β RI and RII expression by immunohistology. (A and B) Same results were obtained in three independent experiments.
Figure 6.
Multiple suppressive mechanisms play a role in peripheral allergen tolerance. (A) Endogenous IL-10, TGF-β, or both as well as CTLA-4, PD-1, or both were neutralized in Der p 1–stimulated PBMCs of healthy individuals. [3H]Thymidine incorporation (TdR), IFN-γ, and IL-13 were determined at day 5. (B) Der p 1–specific proliferation of PBMCs from house dust mite allergic patients was suppressed by 10 times increased frequency of Der p 1–specific, IL-10–secreting T cells (IL-10+). The activity of IL-10, TGF-β, CTLA-4, and PD-1 were neutralized. [3H]Thymidine incorporation (TdR), IFN-γ, and IL-13 were determined at day 5. (control) Isotype control antibody. (A and B) Same results were obtained in four independent experiments (two Bet v1 and two Der p 1) all performed with freshly purified cells without in vitro expansion. Bet v 1 stimulation in birch pollen–allergic individuals gave similar results. All of the neutralization experiments were significantly different from the control and IL-10–secreting T cell–suppressed condition at 0.3 μM allergen doses. P < 0.001.
Similar articles
- Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: the role of T regulatory cells.
Taylor A, Verhagen J, Blaser K, Akdis M, Akdis CA. Taylor A, et al. Immunology. 2006 Apr;117(4):433-42. doi: 10.1111/j.1365-2567.2006.02321.x. Immunology. 2006. PMID: 16556256 Free PMC article. Review. - Mechanisms of allergen specific immunotherapy--T-cell tolerance and more.
Jutel M, Akdis M, Blaser K, Akdis CA. Jutel M, et al. Allergy. 2006 Jul;61(7):796-807. doi: 10.1111/j.1398-9995.2006.01175.x. Allergy. 2006. PMID: 16792576 Review. - The T cell response to major grass allergens is regulated and includes IL-10 production in atopic but not in non-atopic subjects.
Domdey A, Liu A, Millner A, Lund K, Jacobi H, Malling HJ, Søndergaard I, Würtzen PA. Domdey A, et al. Int Arch Allergy Immunol. 2010;152(3):243-54. doi: 10.1159/000283033. Epub 2010 Feb 11. Int Arch Allergy Immunol. 2010. PMID: 20150742 - T regulatory cells in allergy and health: a question of allergen specificity and balance.
Taylor A, Verhagen J, Akdis CA, Akdis M. Taylor A, et al. Int Arch Allergy Immunol. 2004 Sep;135(1):73-82. doi: 10.1159/000080523. Epub 2004 Aug 30. Int Arch Allergy Immunol. 2004. PMID: 15340251 Review.
Cited by
- Immunological factors, important players in the development of asthma.
Wang Y, Liu L. Wang Y, et al. BMC Immunol. 2024 Jul 26;25(1):50. doi: 10.1186/s12865-024-00644-w. BMC Immunol. 2024. PMID: 39060923 Free PMC article. Review. - Beyond Immune Balance: The Pivotal Role of Decidual Regulatory T Cells in Unexplained Recurrent Spontaneous Abortion.
Li QH, Zhao QY, Yang WJ, Jiang AF, Ren CE, Meng YH. Li QH, et al. J Inflamm Res. 2024 May 1;17:2697-2710. doi: 10.2147/JIR.S459263. eCollection 2024. J Inflamm Res. 2024. PMID: 38707955 Free PMC article. Review. - A Potential Role of Interleukin-5 in the Pathogenesis and Progression of Amyotrophic Lateral Sclerosis: A New Molecular Perspective.
Moțățăianu A, Andone S, Stoian A, Bălașa R, Huțanu A, Sărmășan E. Moțățăianu A, et al. Int J Mol Sci. 2024 Mar 28;25(7):3782. doi: 10.3390/ijms25073782. Int J Mol Sci. 2024. PMID: 38612591 Free PMC article. - Increased Nasal Blimp1 + Treg Cells After Sublingual Immunotherapy Reflect the Efficacy of Treatment in Allergic Rhinitis.
Pan Y, Zhang X, Geng H, Yu Y, Liu J, Li M, Yang H, Yuan Y, Xu Y, Wu Y, Wu G, Ma X, Cheng L. Pan Y, et al. Adv Ther. 2024 Apr;41(4):1698-1710. doi: 10.1007/s12325-024-02819-8. Epub 2024 Mar 5. Adv Ther. 2024. PMID: 38443650 - Discrepancy in the suppressive function of regulatory T cells in allergic asthmatic vs. allergic rhinitis subjects upon low-dose allergen challenges.
Klein M, Plante S, Boulay MÈ, Boulet LP, Chakir J. Klein M, et al. Front Allergy. 2023 Dec 1;4:1296601. doi: 10.3389/falgy.2023.1296601. eCollection 2023. Front Allergy. 2023. PMID: 38106504 Free PMC article.
References
- Teale, J.M., and N.R. Klinman. 1980. Tolerance as an active process. Nature. 288:385–387. - PubMed
- Parijs, L.V., and A.K. Abbas. 1998. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science. 280:243–247. - PubMed
- Mosmann, T.R., H. Cherwinski, M.W. Bond, M.A. Giedlin, and R.L. Coffman. 1986. Two types of murine helper T cell clones. 1. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348–2357. - PubMed
- Romagnani, S. 1994. Lymphokine production by human T cells in disease states. Annu. Rev. Immunol. 12:227–257. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials